Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms.
BCR-ABL1
UAS/hsp70-Gal4
chronic myeloid leukemia (CML)
embryonic development
hematopoiesis
transgenic animal model
zebrafish
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
19 02 2021
19 02 2021
Historique:
received:
30
12
2020
revised:
12
02
2021
accepted:
12
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Zebrafish has proven to be a versatile and reliable experimental in vivo tool to study human hematopoiesis and model hematological malignancies. Transgenic technologies enable the generation of specific leukemia types by the expression of human oncogenes under specific promoters. Using this technology, a variety of myeloid and lymphoid malignancies zebrafish models have been described. Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasia characterized by the
Identifiants
pubmed: 33669758
pii: cells10020445
doi: 10.3390/cells10020445
pmc: PMC7922348
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Mol Cell Biol. 2015 Mar;35(5):789-804
pubmed: 25512612
Adv Immunol. 2003;81:253-330
pubmed: 14711058
Cancer Cell. 2020 Apr 13;37(4):530-542
pubmed: 32289275
Nat Protoc. 2008;3(1):59-69
pubmed: 18193022
Leukemia. 2013 Nov;27(11):2229-41
pubmed: 23625115
Dev Cell. 2005 Jan;8(1):97-108
pubmed: 15621533
Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):620-633
pubmed: 30593895
Leuk Lymphoma. 2018 Jul;59(7):1523-1538
pubmed: 28972424
Int J Mol Sci. 2019 Dec 05;20(24):
pubmed: 31817512
J Clin Med. 2020 Jun 02;9(6):
pubmed: 32498406
Blood Adv. 2019 Dec 23;3(24):4280-4290
pubmed: 31869412
Blood. 2009 Jul 9;114(2):279-89
pubmed: 19433857
Br J Haematol. 2008 Aug;142(4):571-82
pubmed: 18537972
Leukemia. 2020 Apr;34(4):966-984
pubmed: 32127639
Blood. 2001 Aug 1;98(3):643-51
pubmed: 11468162
Dev Cell. 2004 Jul;7(1):133-44
pubmed: 15239961
Blood. 2015 Sep 10;126(11):1302-13
pubmed: 26186938
Curr Hematol Malig Rep. 2018 Dec;13(6):435-445
pubmed: 30370478
Eur J Haematol. 2019 Sep;103(3):272-273
pubmed: 31233644
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Semin Cancer Biol. 2018 Aug;51:180-197
pubmed: 28778403
Cancer. 2019 Mar 1;125(5):712-725
pubmed: 30480765
Leukemia. 2009 Oct;23(10):1825-35
pubmed: 19516274
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13711-6
pubmed: 12370418
Leukemia. 2016 Jul;30(7):1493-501
pubmed: 27044711
Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):239-49
pubmed: 10575549
Front Oncol. 2019 Jul 03;9:603
pubmed: 31334123
Int J Mol Sci. 2019 Apr 13;20(8):
pubmed: 31013941
Oncogene. 2004 Sep 20;23(43):7233-46
pubmed: 15378083
Toxicol Pathol. 2011 Aug;39(5):759-75
pubmed: 21636695
Cancer Cell Int. 2012 Jun 18;12(1):28
pubmed: 22709531
J Hematol Oncol. 2015 Mar 28;8:29
pubmed: 25884214
Blood Cancer J. 2015 Sep 18;5:e347
pubmed: 26383820
N Engl J Med. 1999 Jul 15;341(3):164-72
pubmed: 10403855
Blood. 2005 May 15;105(10):3995-4003
pubmed: 15657179
Acta Haematol. 2016;136(2):65-70
pubmed: 27161125
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7622-7
pubmed: 12032333
Leuk Res. 1998 Dec;22(12):1085-96
pubmed: 9922073
Int J Mol Sci. 2019 Oct 25;20(21):
pubmed: 31731471
Chin J Cancer. 2016 May 27;35:48
pubmed: 27233483
Curr Hematol Malig Rep. 2019 Dec;14(6):501-506
pubmed: 31696382
Blood. 2009 Feb 19;113(8):1619-30
pubmed: 18827185
Dev Biol. 1998 May 15;197(2):248-69
pubmed: 9630750
Mol Genet Genomics. 2013 Jun;288(5-6):231-42
pubmed: 23674148
Case Rep Oncol. 2020 Oct 15;13(3):1263-1269
pubmed: 33250741
Am J Hematol. 2014 Feb;89(2):119-24
pubmed: 24122886
Oncotarget. 2017 May 23;8(21):34736-34749
pubmed: 28423730
Sci China Life Sci. 2015 Dec;58(12):1202-8
pubmed: 26582013
Genes Dev. 1998 Mar 1;12(5):621-6
pubmed: 9499398
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Haematologica. 2020 Mar;105(3):674-686
pubmed: 31289206
Br J Haematol. 1999 Dec;107(4):731-8
pubmed: 10606877
Blood. 2010 Jan 21;115(3):626-35
pubmed: 19965668
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Am J Clin Pathol. 2009 Aug;132(2):250-60
pubmed: 19605820
Cancer Med. 2019 May;8(5):2041-2055
pubmed: 30950237
FEBS Lett. 2016 Nov;590(22):4016-4033
pubmed: 27616157
Leuk Res. 2002 Jun;26(6):551-9
pubmed: 12007503
Blood. 1995 Oct 15;86(8):3173-80
pubmed: 7579412
Int J Hematol. 2015 Jan;101(1):3-4
pubmed: 25380681
J Exp Med. 2017 Oct 2;214(10):2875-2887
pubmed: 28878000
Haematologica. 2019 Apr;104(4):717-728
pubmed: 30409797
Methods Mol Biol. 2016;1481:81-94
pubmed: 27590154
Leuk Res. 1996 Jun;20(6):473-80
pubmed: 8709619
Wiley Interdiscip Rev Dev Biol. 2018 May;7(3):e312
pubmed: 29436122
Br J Haematol. 2009 Aug;146(3):247-56
pubmed: 19466976
Mol Med Rep. 2018 Nov;18(5):4739-4746
pubmed: 30221726
Br J Haematol. 2007 Jun;137(5):443-53
pubmed: 17488487
Zebrafish. 2019 Jun;16(3):233-239
pubmed: 30855222
PLoS One. 2019 Jul 18;14(7):e0218444
pubmed: 31318870
Haematologica. 2020 Jan 31;105(2):387-397
pubmed: 31101753
Dev Dyn. 2005 Jun;233(2):680-94
pubmed: 15844196
Blood. 2001 Nov 15;98(10):3087-96
pubmed: 11698295
Br J Haematol. 2007 Jul;138(2):169-75
pubmed: 17593023
Curr Opin Genet Dev. 2015 Feb;30:73-9
pubmed: 26070506
Hum Pathol. 1985 Aug;16(8):808-14
pubmed: 3860469
Ann Intern Med. 2003 May 20;138(10):819-30
pubmed: 12755554
J Clin Med. 2020 Nov 27;9(12):
pubmed: 33261150
Med J Malaysia. 2016 Apr;71(2):85-7
pubmed: 27326952
Front Oncol. 2019 Oct 25;9:1132
pubmed: 31709190
Cell Oncol (Dordr). 2015 Dec;38(6):407-18
pubmed: 26458816
Adv Genet. 2016;95:65-87
pubmed: 27503354
Curr Hematol Malig Rep. 2012 Jun;7(2):87-93
pubmed: 22328017
Int J Lab Hematol. 2020 Apr;42(2):101-108
pubmed: 31841277
Genes (Basel). 2019 Aug 13;10(8):
pubmed: 31412687
Cureus. 2020 Jun 23;12(6):e8788
pubmed: 32596094